SCHEMBL2082274

SCHEMBL2082274

CC(C)(C)OC(=O)NCCCCNCc1ncccc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
PDCD1 Q15116 1/20 0.45
CD274 Q9NZQ7 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
PDPK1 O15530 1/20 0.44
CCNB2 O95067 1/20 0.44
PRKCB P05771 1/20 0.44
CDK1 P06493 1/20 0.44
LYN P07948 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
GSK3B P49841 1/20 0.44
RPS6KA3 P51812 1/20 0.44
CCNA1 P78396 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44
SKP2 Q13309 1/20 0.44
MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30069416 0.85 CYP3A4 (0.49) CYP3A4TDP1PDPK1CCNB2PRKCB
SCHEMBL21744312 0.85 CYP3A4 (0.49) CYP3A4TDP1PDPK1CCNB2PRKCB
SCHEMBL2081506 0.84 CYP3A4 (0.50) CYP3A4TDP1PDPK1CCNB2PRKCB
SCHEMBL2085522 0.83 CYP3A4 (0.49) CYP3A4TDP1PDPK1CCNB2PRKCB
SCHEMBL21744316 0.82 DRD2 (0.50) CYP3A4TDP1PDPK1CCNB2PRKCB
SCHEMBL30069418 0.82 DRD2 (0.50) CYP3A4TDP1PDPK1CCNB2PRKCB
SCHEMBL2085321 0.82 CYP3A4 (0.48) CYP3A4TDP1PDPK1CCNB2PRKCB
SCHEMBL21744449 0.81 CYP3A4 (0.47) CYP3A4TDP1MAOAMAOBKDM4E
SCHEMBL2085122 0.81 CYP3A4 (0.47) CYP3A4TDP1MAOAMAOBNPSR1
SCHEMBL30069419 0.81 CYP3A4 (0.47) CYP3A4TDP1MAOAMAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613613-B1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORP (US) 2021-06-02 EP disclosed
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US disclosed
EP-1613613-A4 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2009-03-25 EP disclosed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US disclosed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US disclosed
EP-1613613-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-01-11 EP disclosed
WO-2004091518-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2004-10-28 WO disclosed
US-20040209921-A1 CXCR4 chemokine receptor binding comounds ANORMED CORPORATION (CA) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209921-A1 CXCR4 chemokine receptor binding comounds CXCR4, CXCR1, CXCR3 CYP3A4 3372/4885PDCD1 1356/4885CD274 402/4885
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS CXCR4, CXCR1, CXCR3 CYP3A4 3377/4885PDCD1 1906/4885CD274 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.